These drug reviews aim to give objective
information and guidance to commissioners of health services, prescribers and others both on clinical aspects of the subject and on arrangements for prescribing. The reports are prepared by a multidisciplinary team within the RDTC and reviewed by health authority personnel and appropriate external specialists. However, the responsibility for the content and conclusions rests solely with the RDTC.
This information is produced for use by NHS healthcare professionals. See site disclaimer.
NETAG treatment recommendations can be accessed via www.netag.nhs.uk
| 
